Gene expression profiling of breast cancer.
暂无分享,去创建一个
[1] Xin Jin,et al. K-Means Clustering , 2010, Encyclopedia of Machine Learning.
[2] V. Marchesi. The relevance of research on red cell membranes to the understanding of complex human disease: a personal perspective. , 2008, Annual review of pathology.
[3] Bradley P. Coe,et al. Resolving the resolution of array CGH. , 2007, Genomics.
[4] L. Miele,et al. Cancer stem cells – an old idea that’s new again: implications for the diagnosis and treatment of breast cancer , 2007, Expert opinion on biological therapy.
[5] R. Beroukhim,et al. Molecular definition of breast tumor heterogeneity. , 2007, Cancer cell.
[6] I. Ellis,et al. A gene-expression signature to predict survival in breast cancer across independent data sets , 2007, Oncogene.
[7] J. Massagué. Sorting out breast-cancer gene signatures. , 2007, The New England journal of medicine.
[8] G. Sherlock,et al. The prognostic role of a gene signature from tumorigenic breast-cancer cells. , 2007, The New England journal of medicine.
[9] A. Dupuy,et al. Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting. , 2007, Journal of the National Cancer Institute.
[10] Mads Thomassen,et al. Prediction of metastasis from low‐malignant breast cancer by gene expression profiling , 2006, International journal of cancer.
[11] S. Krishnamurthy. Morphological and Immunophenotypic Analysis of Breast Carcinomas With Basal and Myoepithelial Differentiation , 2007 .
[12] Susmita Datta,et al. Evaluation of clustering algorithms for gene expression data , 2006, BMC Bioinformatics.
[13] Ajay N. Jain,et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. , 2006, Cancer cell.
[14] T. Nielsen,et al. Deconstructing the molecular portrait of basal-like breast cancer. , 2006, Trends in molecular medicine.
[15] Joshy George,et al. Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. , 2006, Cancer research.
[16] Carsten Peterson,et al. Gene expression profilers and conventional clinical markers to predict distant recurrences for premenopausal breast cancer patients after adjuvant chemotherapy. , 2006, European journal of cancer.
[17] A. Witteveen,et al. Converting a breast cancer microarray signature into a high-throughput diagnostic test , 2006, BMC Genomics.
[18] M. J. van de Vijver,et al. Classification of ductal carcinoma in situ by gene expression profiling , 2006, Breast Cancer Research.
[19] Greg Finak,et al. Gene expression signatures of morphologically normal breast tissue identify basal-like tumors , 2006, Breast Cancer Research.
[20] Marc Buyse,et al. Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial , 2006, Nature Clinical Practice Oncology.
[21] J. Ioannidis. Gene expression profiling for individualized breast cancer chemotherapy: success or not? , 2006, Nature Clinical Practice Oncology.
[22] Amy V Kapp,et al. Discovery and validation of breast cancer subtypes , 2006, BMC Genomics.
[23] L. V. van't Veer,et al. Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. , 2006, Journal of the National Cancer Institute.
[24] Susmita Datta,et al. Methods for evaluating clustering algorithms for gene expression data using a reference set of functional classes , 2006, BMC Bioinformatics.
[25] M. Cronin,et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] A. Nobel,et al. Concordance among Gene-Expression – Based Predictors for Breast Cancer , 2011 .
[27] J. Cuzick,et al. Impact of chemotherapy regimens prior to endocrine therapy , 2006, Cancer.
[28] Yudi Pawitan,et al. Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients , 2006, Breast Cancer Research.
[29] D. Ross,et al. Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] L. Matthews,et al. Accurate Prediction of BRCA1 and BRCA2 Heterozygous Genotype Using Expression Profiling after Induced DNA Damage , 2006, Clinical Cancer Research.
[31] W. Gerald,et al. An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen , 2006, Oncogene.
[32] John Quackenbush. Microarray analysis and tumor classification. , 2006, The New England journal of medicine.
[33] C. Perou,et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. , 2006, JAMA.
[34] T. Sørlie,et al. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms , 2006, BMC Genomics.
[35] Yi Zhang,et al. Genes associated with breast cancer metastatic to bone. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] A. Nobel,et al. The molecular portraits of breast tumors are conserved across microarray platforms , 2006, BMC Genomics.
[37] Zhiyuan Hu,et al. Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] J. Foekens,et al. Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] L. Ein-Dor,et al. Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[40] F. Couch,et al. A Two-Gene Expression Ratio of Homeobox 13 and Interleukin-17B Receptor for Prediction of Recurrence and Survival in Women Receiving Adjuvant Tamoxifen , 2006, Clinical Cancer Research.
[41] M. Bissell,et al. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. , 2006, Annual review of cell and developmental biology.
[42] M. J. van de Vijver,et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. , 2006, Journal of the National Cancer Institute.
[43] Andrea Bild,et al. Gene Expression Profiles of Multiple Breast Cancer Phenotypes and Response to Neoadjuvant Chemotherapy , 2006, Clinical Cancer Research.
[44] Trevor Hastie,et al. Gene Expression Programs in Response to Hypoxia: Cell Type Specificity and Prognostic Significance in Human Cancers , 2006, PLoS medicine.
[45] Maqc Consortium. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements , 2006, Nature Biotechnology.
[46] Zhiyuan Hu,et al. Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay , 2006, Breast Cancer Research.
[47] J. Forbes,et al. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. , 2005, The New England journal of medicine.
[48] Manuela Gariboldi,et al. Limits of predictive models using microarray data for breast cancer clinical treatment outcome. , 2005, Journal of the National Cancer Institute.
[49] J. Bergh,et al. Better characterization of estrogen receptor (ER) positive luminal subtypes of breast cancer using genomic grade. , 2005 .
[50] M. Cassone,et al. Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysis , 2005 .
[51] I. Petersen,et al. Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival , 2005, Oncogene.
[52] Roland Eils,et al. Cross-platform analysis of cancer microarray data improves gene expression based classification of phenotypes , 2005, BMC Bioinformatics.
[53] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[54] P. Hall,et al. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[55] S. Swain,et al. Gene Expression Patterns and Profile Changes Pre- and Post-Erlotinib Treatment in Patients with Metastatic Breast Cancer , 2005, Clinical Cancer Research.
[56] Roman Rouzier,et al. Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy , 2005, Clinical Cancer Research.
[57] Michael Gnant,et al. Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial , 2005, The Lancet.
[58] Chiara Benedetto,et al. Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[59] Andy J. Minn,et al. Genes that mediate breast cancer metastasis to lung , 2005, Nature.
[60] M. J. van de Vijver,et al. Changes in gene expression associated with response to neoadjuvant chemotherapy in breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[61] K. K. Dobbin,et al. Characterizing dye bias in microarray experiments , 2005, Bioinform..
[62] Yudong D. He,et al. A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients. , 2005, Cancer research.
[63] Tina Hernandez-Boussard,et al. Determination of Stromal Signatures in Breast Carcinoma , 2005, PLoS biology.
[64] Karen A Gelmon,et al. Population-based validation of the prognostic model ADJUVANT! for early breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[65] Daniel Birnbaum,et al. Gene expression profiling identifies molecular subtypes of inflammatory breast cancer. , 2005, Cancer research.
[66] Howard Y. Chang,et al. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[67] Syed Mohsin,et al. Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[68] J. Foekens,et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.
[69] Stefan Michiels,et al. Prediction of cancer outcome with microarrays: a multiple random validation strategy , 2005, The Lancet.
[70] Maurice P H M Jansen,et al. Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[71] Hans-Dieter Pohlenz,et al. Distinct gene expression patterns in a tamoxifen-sensitive human mammary carcinoma xenograft and its tamoxifen-resistant subline MaCa 3366/TAM. , 2005, Molecular cancer therapeutics.
[72] Eytan Domany,et al. Outcome signature genes in breast cancer: is there a unique set? , 2004, Breast Cancer Research.
[73] Zang Ai-hua,et al. Stem Cells,Cancer and Cancer Stem Cells , 2005 .
[74] M. Cronin,et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.
[75] F. Bertucci,et al. Gene Expression Profiling for Molecular Characterization of Inflammatory Breast Cancer and Prediction of Response to Chemotherapy , 2004, Cancer Research.
[76] Alok J. Saldanha,et al. Java Treeview - extensible visualization of microarray data , 2004, Bioinform..
[77] R. Henkelman,et al. Identification of human brain tumour initiating cells , 2004, Nature.
[78] A. Gown,et al. Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma , 2004, Clinical Cancer Research.
[79] M. Fernö,et al. "Good Old" clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers. , 2004, European journal of cancer.
[80] Charles M Perou,et al. Statistical modeling for selecting housekeeper genes , 2004, Genome Biology.
[81] Rameen Beroukhim,et al. Molecular characterization of the tumor microenvironment in breast cancer. , 2004, Cancer cell.
[82] J. Stec,et al. Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[83] C. Perou,et al. Cell-Type-Specific Responses to Chemotherapeutics in Breast Cancer , 2004, Cancer Research.
[84] Petri Auvinen,et al. Are data from different gene expression microarray platforms comparable? , 2004, Genomics.
[85] David Botstein,et al. Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. , 2004, Molecular biology of the cell.
[86] Wei Wang,et al. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. , 2004, Cancer cell.
[87] R. Tibshirani,et al. Semi-Supervised Methods to Predict Patient Survival from Gene Expression Data , 2004, PLoS biology.
[88] D. Ransohoff. Rules of evidence for cancer molecular-marker discovery and validation , 2004, Nature Reviews Cancer.
[89] M. van de Rijn,et al. Applications of microarrays to histopathology , 2004, Histopathology.
[90] Ash A. Alizadeh,et al. Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds , 2004, PLoS biology.
[91] Dennis C. Sgroi,et al. Laser Capture Microdissection and Advanced Molecular Analysis of Human Breast Cancer , 2003, Journal of Mammary Gland Biology and Neoplasia.
[92] Carlos Caldas,et al. Expression microarray reproducibility is improved by optimising purification steps in RNA amplification and labelling , 2004, BMC Genomics.
[93] Annuska M Glas,et al. Gene expression profiles of primary breast tumors maintained in distant metastases , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[94] Jane Fridlyand,et al. Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis. , 2003, Cancer research.
[95] Minetta C. Liu,et al. Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling , 2003, Oncogene.
[96] Philip M. Long,et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[97] R. Tibshirani,et al. Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[98] Tatjana Crnogorac-Jurcevic,et al. Combination of microdissection and microarray analysis to identify gene expression changes between differentially located tumour cells in breast cancer , 2003, Oncogene.
[99] I. Fidler,et al. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.
[100] M. West,et al. Gene expression predictors of breast cancer outcomes , 2003, The Lancet.
[101] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.
[102] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[103] A. Børresen-Dale,et al. TP53 and breast cancer , 2003, Human mutation.
[104] C. Sotiriou,et al. Molecular profiles of invasive mucinous and ductal carcinomas of the breast: a molecular case study. , 2003, Cancer genetics and cytogenetics.
[105] Susmita Datta,et al. Comparisons and validation of statistical clustering techniques for microarray gene expression data , 2003, Bioinform..
[106] M. Ringnér,et al. Molecular classification of familial non-BRCA1/BRCA2 breast cancer , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[107] T. Speed,et al. Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.
[108] Andrew J. Holloway,et al. Options available—from start to finish—for obtaining data from DNA microarrays II , 2002, Nature Genetics.
[109] John Quackenbush. Microarray data normalization and transformation , 2002, Nature Genetics.
[110] R. Tibshirani,et al. Copyright © American Society for Investigative Pathology Short Communication Expression of Cytokeratins 17 and 5 Identifies a Group of Breast Carcinomas with Poor Clinical Outcome , 2022 .
[111] D. Coradini,et al. Infiltrating ductal and lobular breast carcinomas are characterised by different interrelationships among markers related to angiogenesis and hormone dependence , 2002, British Journal of Cancer.
[112] John D. Storey. A direct approach to false discovery rates , 2002 .
[113] S. Dudoit,et al. A prediction-based resampling method for estimating the number of clusters in a dataset , 2002, Genome Biology.
[114] Geoffrey J McLachlan,et al. Selection bias in gene extraction on the basis of microarray gene-expression data , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[115] Lucila Ohno-Machado,et al. Analysis of matched mRNA measurements from two different microarray technologies , 2002, Bioinform..
[116] S. Dudoit,et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. , 2002, Nucleic acids research.
[117] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[118] Van,et al. A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.
[119] Aled M. Edwards,et al. Unfolding of Microarray Data , 2002, J. Comput. Biol..
[120] A. Cleton-Jansen. E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer? , 2001, Breast Cancer Research.
[121] R. Spang,et al. Predicting the clinical status of human breast cancer by using gene expression profiles , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[122] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[123] Carsten O. Peterson,et al. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. , 2001, Cancer research.
[124] J. Foekens,et al. Molecular profiles of BRCA1-mutated and matched sporadic breast tumours: relation with clinico-pathological features , 2001, British Journal of Cancer.
[125] S. Ethier,et al. Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. , 2001, Cancer research.
[126] M. Ringnér,et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks , 2001, Nature Medicine.
[127] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[128] T. Aas,et al. Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer. , 2001, Cancer research.
[129] E. Dougherty,et al. Gene-expression profiles in hereditary breast cancer. , 2001, The New England journal of medicine.
[130] P. Ravdin,et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[131] C. Li,et al. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[132] Trevor Hastie,et al. The Elements of Statistical Learning , 2001 .
[133] C. Li,et al. Analyzing high‐density oligonucleotide gene expression array data , 2001, Journal of cellular biochemistry.
[134] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[135] R. Vossen,et al. Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer. , 2000, Cancer research.
[136] M J O'Hare,et al. Linking gene expression patterns to therapeutic groups in breast cancer. , 2000, Cancer research.
[137] Christian A. Rees,et al. Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.
[138] D Haussler,et al. Knowledge-based analysis of microarray gene expression data by using support vector machines. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[139] Ash A. Alizadeh,et al. Genome-wide analysis of DNA copy number variation in breast cancer using DNA microarrays , 1999, Nature Genetics.
[140] Ash A. Alizadeh,et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays , 1999, Nature Genetics.
[141] Christian A. Rees,et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[142] J. Mesirov,et al. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[143] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[144] Osborne Ck,et al. Tamoxifen in the Treatment of Breast Cancer , 1998 .
[145] J. Kononen,et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.
[146] C. Osborne,et al. Tamoxifen in the treatment of breast cancer. , 1998, The New England journal of medicine.
[147] P. Brown,et al. A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. , 1996, Genome research.
[148] Ronald W. Davis,et al. Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.
[149] S. Pinder,et al. Histological grading of breast carcinomas: a study of interobserver agreement. , 1995, Human pathology.
[150] F. Kianifard. Applied Multivariate Data Analysis: Volume II: Categorical and Multivariate Methods , 1994 .
[151] J. D. Jobson,et al. Categorical and multivariate methods , 1992 .
[152] Ali S. Hadi,et al. Finding Groups in Data: An Introduction to Chster Analysis , 1991 .
[153] H. Dvorak. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.
[154] Peter A. Lachenbruch,et al. Classification: Methods for the Exploratory Analythi of Multivariate Data , 1982 .
[155] J. A. Hartigan,et al. A k-means clustering algorithm , 1979 .
[156] J. Hartigan. Clustering Algorithms , 1975 .